Data coverage, completeness and provenance for BOTANIX PHARMACEUTICALS LTD in the Stock Market API — Health Care · Biotechnology.
Source date: 2026-10-30T05:12:06. Source: yfinance. Collection time is shown separately and does not establish a trade date.
| Date | Close | Currency | Source | Adjustment basis |
|---|---|---|---|---|
| 2026-10-30 | 0.0100 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-29 | 0.0120 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-28 | 0.0110 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-27 | 0.0110 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-26 | 0.0130 | AUD | yfinance | Split- and dividend-adjusted close |
GET /api/v1/companies/BOT/prices · Price parameters and adjustment semantics
Botanix Pharmaceuticals Limited, a pharmaceutical company, engages in the research and commercialization of solutions for skin diseases and infections in Australia and the United States. The company's lead product is Sofdra (sofpironium) topical gel, a prescription anticholinergic medicine used to treat underarm sweating in adults and children 9 years of age and older. It also develops BTX 1503, a transdermal gel formulation, which is in Phase 3 clinical trial for the treatment of serious acne in adults and teenagers; BTX 1702 that is in Phase 1b/2 clinical trial to treat papulopustular rosacea; BTX 1204A for treating atopic dermatitis; and BTX 1801, which has been completed Phase 2a clinical trial for the treatment of staphylococcus aureus and methicillin resistant staphylococcus aureus. The company was incorporated in 1984 and is based in Melbourne, Australia.
Website: https://www.botanixpharma.com · Profile fields populated: 60%
Share of stored fields populated in the anchor reporting period (FY2026), primary source yfinance. Full per-field breakdown: GET /api/v1/companies/BOT/financials.
Stored values for the most recent fiscal-year periods, with per-period field counts and the primary source each period came from. Values are shown at reported scale without interpretation.
| Period | Period end | Revenue | Net income | Total assets | Total equity | Fields populated | Source |
|---|---|---|---|---|---|---|---|
| FY2026 (AUD) | 2026-06-30 | 29 | yfinance | ||||
| FY2025 (AUD) | 2025-06-30 | 31 | yfinance | ||||
| FY2024 (AUD) | 2024-06-30 | 29 | yfinance | ||||
| FY2023 (AUD) | 2023-06-30 | 29 | yfinance |
The endpoints below describe available datasets for this listing. Missing fields remain unknown. Free API keys — no card required.
Name, sector, industry, HQ, employees, market cap, source-tagged.
GET /api/v1/companies/BOT
Multi-year statements with per-field source tags and completeness.
GET /api/v1/companies/BOT/financials
P/E, P/B, ROE, ROA, margins, EPS, debt/equity — formulas documented.
GET /api/v1/companies/BOT/metrics/summary
Report PDFs with LLM-ready markdown conversions where available.
GET /api/v1/companies/BOT/filings
Dated press releases and announcements with source links.
GET /api/v1/companies/BOT/news
Create a free key, then:
curl -H "X-API-Key: KEY" https://stockmarketapi.ai/api/v1/companies/BOT
Free tier — instant API key. Built for AI agents.